Applied DNA Sciences Inc (NASDAQ:APDN)
| 10.37 Delayed Data As of 4:42pm ET |  -0.70 / -6.32%Today’s Change | 2.52 Today|||52-Week Range 16.39 | +103.33% Year-to-Date |
Latest APDN News | Press Releases
No recent news for Applied DNA Sciences Inc.
Today’s Trading
| Previous close | 11.07 |
| Today’s open | 10.48 |
| Day’s range | 10.26 - 11.61 |
| Volume | 37,099 |
| Average volume (3 months) | 841,919 |
| Market cap | $77.8M |
Data as of 4:42pm ET, 01/27/2021
Growth & Valuation
| Earnings growth (last year) | +65.69% |
| Earnings growth (this year) | +65.66% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -64.16% |
| P/E ratio | NM |
| Price/Sales | 15.68 |
| Price/Book | 9.37 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| FSTXF-Star Therapeutics ... | -0.88 | -9.59% |
| BLRXBioLine RX Ltd | -0.06 | -2.45% |
| DFFNDiffusion Pharmaceut... | -0.05 | -4.00% |
| CLRBCellectar Bioscience... | +0.02 | +1.34% |
Data as of 3:59pm ET, 01/27/2021
Financials
| Next reporting date | February 11, 2021 |
| EPS forecast (this quarter) | -$0.54 |
| Annual revenue (last year) | $1.9M |
| Annual profit (last year) | -$13.0M |
| Net profit margin | -674.46% |
Profile
Sector Commercial Services |
Industry Miscellaneous Commercial Services |
No executives to display |
Corporate headquarters Stony Brook, New York |
Forecasts
